# Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town

> **NCT00460590** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 36 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** MVA 85A

## Key facts

- **NCT ID:** NCT00460590
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460590, "Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00460590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*